Spinal Tech

Alphatec's CEO, Patrick Miles, disposed 179,375 company shares for about $12.46 to $13 per share, Seeking Alpha reported Sept. 28.

Centinel Spine's Prodisc C Vivo and C SK cervical disc implants reached 2,500 U.S. cases, the devicemaker said Sept. 28.

CTL Amedica recently landed electronic catalog government contract approval from the U.S. Defense Logistics Agency.

Onward's ARC-IM spinal stimulator was implanted in the first human patient, the devicemaker said Sept. 27.

The FDA gave ZimVie's Mobi-C cervical disc hybrid investigational device exemption, the devicemaker said Sept. 26.

Large spine and orthopedic mergers have closed this year, and smaller device companies have sought to get their own slice of the pie during the third quarter.

The artificial disc replacement market is expexted to surpass $1.3 billion by 2030, according to Vantage Market Research.

Patrick Miles, CEO of Alphatec, sold 180,000 shares of the company for about $2.42 million, Seeking Alpha reported Sept. 20.

Carlsmed received its second FDA breakthrough device designation for Aprevo, the medtech company said Sept. 20.

ChoiceSpine recently received FDA clearance to market its Blackhawk Ti 3D-printed cervical spacer system.